The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

Novo Nordisk’s NVO shares lost 5.3% on Friday after Medicare issued a press release selecting the company’s popular ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for alternative ways to administer anti-obesity drugs. | Found is offering a cheaper, ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...

The FDA approved Novo Nordisk’s semaglutide tablet Rybelsus for adults with diabetes but not for weight management. Mild gastrointestinal issues, such as nausea and diarrhea, were the most ...

Our editors also may be in touch with follow-up questions. Ozempic is a brand-name, injectable semaglutide medication. It’s prescribed, alongside dietary changes and exercise, to adults with ...

Rybelsus (semaglutide) is a prescription drug that’s used to treat type 2 diabetes. The cost of Rybelsus may depend on factors such as your dosage, whether you have health insurance, and the ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Found, the leading specialized weight care telehealth platform, announced the expansion of its industry-leading formulary of more than a dozen medications to include compounded oral semaglutide ...